Ghent, Belgium

Erika Morizzo

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 4.7

ph-index = 3

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2018-2024

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Erika Morizzo

Introduction

Erika Morizzo is a prominent inventor based in Ghent, Belgium. She has made significant contributions to the field of biotechnology, particularly in the development of immunoglobulin single variable domains. With a total of five patents to her name, Morizzo's work has the potential to impact various medical applications.

Latest Patents

Morizzo's latest patents include groundbreaking inventions related to immunoglobulin single variable domains (ISVD) capable of binding to serum albumin. The first patent describes amino acid sequences that can effectively bind to serum albumin, focusing on heavy-chain immunoglobulin single variable domains. This invention also encompasses proteins, polypeptides, and other constructs that incorporate these immunoglobulin single variable domains. The second patent reiterates the same innovative concepts, emphasizing the importance of these binding domains in therapeutic applications.

Career Highlights

Erika Morizzo is currently associated with Ablynx N.V., a company known for its pioneering work in biopharmaceuticals. Her role at Ablynx has allowed her to further her research and development efforts in the field of immunology. Morizzo's dedication to innovation has positioned her as a key figure in her area of expertise.

Collaborations

Morizzo collaborates with talented professionals such as Stephanie Staelens and Soren Steffensen. These partnerships enhance her research capabilities and contribute to the advancement of their collective work in biotechnology.

Conclusion

Erika Morizzo's contributions to the field of immunology through her innovative patents and collaborations highlight her as a significant inventor in biotechnology. Her work continues to pave the way for advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…